Jeffrey Jacobson, MD, has completed his MD in Cornell University Medical College, New York, NY, 1977. Dr. Jacobson has been appointed as Professor of Medicine, Professor of Neuroscience and Professor in the Center for Neurovirology at the Lewis Katz School of Medicine at Temple University. Dr. Jacobson is a nationally and internationally-renowned expert in clinical research on HIV and other chronic viral infections. Dr. Jacobson has 118 peer-reviewed publications in high impact journals such as New England Journal of Medicine, Lancet, Nature Medicine, Journal of Infectious Diseases and Annals of Internal Medicine. Dr. Jeffrey M. Jacobson has extensive experience in the care and investigative study of patients with HIV, hepatitis B, and hepatitis C infection. Recently, he has been studying long-acting parenteral antibody and other therapies against HIV infection. He has chaired numerous clinical research studies involving pathogenesis, pharmacokinetics, and treatment in and outside the NIH-sponsored AIDS Clinical Trials Group. In addition, he has chaired several ACTG committees, including the Immunology Committee and the Translational Research and Drug Development Committee, and has been a member of the Scientific Agenda Steering Committee of the ACTG. He has co-chaired the Long Acting Drug Task Force in the ACTG, and currently serves as chair of the Micro-biome Focus Group and co-chair of the Therapeutic Vaccination Focus Group.

Jeffrey Jacobson particular clinical interests are immunology and immuno-pathogenesis of HIV infection, including vaccine and other immune- and gene-based therapies.